InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Solaiman Shereen. Director active across 1 company, notably Myriad Genetics INC. In total, 5 filings have been logged. Activity tracked since 1 March 2023. The latest transaction was filed on 13 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations